Nara Franzin de Moraes

Statistics

Publications

Citations

581

H-Index

Active since

2020

Affiliations

Universidade Estadual Paulista (Unesp)(Current)

Universidade Federal do Rio de Janeiro

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Universidade de Sorocaba

Clinical Research Institute

Nara Franzin de Moraes is an author at Universidade Estadual Paulista (Unesp) specializing in medicine, clinical pharmacology, and infectious diseases.

ORCID

Publications per year

2020–2024

Publications

Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial

Eduardo Ramacciotti, Leandro Barile Agati, Daniela Calderaro et al. · The Lancet · 2021 · 252 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial

Patrícia R. M. Rocco, Pedro Leme Silva, Fernanda Ferreira Cruz et al. · European Respiratory Journal · 2020 · 181 citations · Full text

Medicine, Infectious Diseases, Pharmacology +14

Presumed SARS-CoV-2 Viral Particles in the Human Retina of Patients With COVID-19

Carlla Assis Araújo-Silva, Allexya Affonso Antunes Marcos, Paula M. Marinho et al. · JAMA Ophthalmology · 2021 · 56 citations · Full text

Medicine, Infectious Diseases, Ophthalmology +17

Early use of nitazoxanide in mild Covid-19 disease: randomized, placebo-controlled trial

Patrícia R. M. Rocco, Pedro Leme Silva, Fernanda Ferreira Cruz et al. · medRxiv · 2020 · 30 citations · Full text

Medicine, Infectious Diseases, Pharmacology +10

Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial

Suzana Margareth Lobo, Gaëtan Plantefève, Girish B. Nair et al. · EClinicalMedicine · 2024 · 27 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

1–5 of 7